A b s t r a c t
Chemical testing of urine samples (reagent strip method) and identification and counting of particles is performed routinely to identify and monitor diseases of the kidney and urinary tract. 1 Despite the introduction of an automated system to count particles more than 2 decades ago, there is still a need for manual microscopic examination of urinary sediment owing to the limitations of existing automated counting systems. [2] [3] [4] [5] Unfortunately, manual microscopy is extremely time consuming and has poor precision owing to variations in sediment preparation and counting technique. [6] [7] [8] [9] To improve standardization, the European Confederation of Laboratory Medicine published guidelines for manual counting of particles in uncentrifuged and concentrated urine samples. 10, 11 However, given the large volume of requests for routine urinalysis, improvements in automated systems still are needed to eliminate laborintensive manual microscopy in the clinical laboratory.
The 2 systems currently available to automate manual microscopy are based on different technologies. One is an image-based analysis system that uses a video camera and strobe lamp (stops fluid motion) to detect and sort particles based on predetermined particle dimensions. The first of these systems was introduced in the mid-1980s. 12 The other type of system was developed in the mid-1990s and is based on the principle of flow cytometry. 13 This system classifies particles based on fluorescent intensity (cells are stained with 2 fluorescent dyes), electrical impedance, and forward angle light scatter. Both of these systems have improved precision and sample throughput compared with manual microscopy. 2, 7 The major drawback of older image-based systems has been that they require continuous monitoring of images by the operator and do not have walk-away capability. Although flow cytometric systems do not have to be monitored continuously, they provide only scattergram analysis, limiting the number of particles that can be differentiated in urine samples.
A next-generation automated image-based urinalysis system, the iQ200 (Iris Diagnostics, Chatsworth, CA), recently received US Food and Drug Administration clearance. The iQ200 is a walk-away system that uses flow imaging analysis technology and Auto-Particle Recognition (APR, Iris Diagnostics) software to classify particles based on multiple parameters. Images are stored and can be viewed on the workstation screen, thereby eliminating the need for manual microscopy in most cases. In the present study, we evaluated the analytic performance of the iQ200 and compared results with those from manual microscopy using standardized Fuchs-Rosenthal counting chambers.
Materials and Methods

Urine Specimens
Specimens submitted to the outpatient laboratory at the University of California Los Angeles Medical Center during a 5-week period for routine urinalysis were selected for the study. The majority of urine samples were from the renal clinic. Approximately 10 urine samples with sufficient volume for additional testing (15-mL volume after routine testing) were identified each day as having normal or abnormal cell counts by the Yellow IRIS urinalysis workstation (Iris Diagnostics).
After analyzing about 50 normal and 50 abnormal urine specimens, additional samples were selected with specific concentrations of RBCs, WBCs, or squamous epithelial cells (ECs) to cover a wide range of concentrations. An effort was made to select a representative number of urine samples with abnormal cell counts near the upper limit of normal. All samples were tested without dilution. For the study, 166 urine samples were analyzed for cells and particles by manual and automated microscopy. All urine samples were tested the same day of collection. The study was reviewed and approved by the human studies committee at the University of California Los Angeles.
Iris Diagnostics iQ200
The iQ200 is an automated urine microscopy analyzer that uses digital imaging and a trained neural network (APR software) to classify and quantitate cells and formed particles in native, uncentrifuged urine. The iQ200 requires a minimum of 3 mL of urine for testing and quantitates particles in 2 µL of sample. The instrument can analyze 60 urine samples per hour. Calibration was performed at the beginning of the study and as needed based on a 1-month calibration stability. Before testing of urine samples each day, iQ Focus, iQ Negative, and iQ Positive control samples (Iris Diagnostics) were run according to the manufacturer's instructions. Each urine sample was divided into aliquots in 2 tubes, analyzed for cells and particles, and expressed as the average of duplicate cell and particle counts. Unless otherwise indicated, the APR software was used to classify and count cells and particles without manual editing of images.
Manual Microscopy
For manual cell counts 3.2-µL Fuchs-Rosenthal counting chambers (catalog No. 3720, Hausser Scientific, Horsham, PA) were used and counted by bright-field microscopy using a 10× ocular. Each side of the chamber has 16 large squares, with each square being 1 × 1 × 0.2 mm deep (0.2 mm 3 ), for a total volume of 0.2 µL. The large squares are further divided into 64 smaller squares. Two technologists loaded both sides of separate counting chambers with well-mixed native urine or control cells. Particles were allowed to settle undisturbed for 5 minutes, and then both sides of the chamber were scanned using a 10× objective to verify an even distribution of particles throughout the counting area.
All 16 large squares on both sides of the chamber (6.4 µL) were examined using a 10× objective to count ECs and casts. The technologists then examined 16 (of 64) evenly distributed small squares in each of the 4 large center squares on both sides of the chamber under high magnification (40× objective) to count RBCs and WBCs. This was equivalent to 1 large square being counted per side (64 squares/1,024 total squares × 3.2 µL = 0.2 µL per side), for a total volume of 0.4 µL. Each technologist then counted the other person's chamber using the same procedure. For correlation with the iQ200, results were expressed as the average of the 4 separate counts for each cell and particle type (2 separate chambers counted by 2 technologists).
Precision Studies
Within-run imprecision was evaluated by counting cells in individual urine samples a total of 20 times during a single day. The mean and coefficient of variation (CV) for each sample were calculated, and results for different urine samples with similar RBC, WBC, or EC counts were grouped together and expressed as a range within each of the groups. Each group contained results from 5 urine samples. Imprecision also was evaluated at low cell numbers by making dilutions of urine samples with initial cell counts around 30 × 10 6 /L using a cell-free urine pool. Each urine sample was tested before dilution and at each dilution a total of 20 times during a single day. For between-run imprecision, glutaraldehyde-preserved human RBCs (positive control cells provided by the manufacturer) were diluted in Iris Diluent (Iris Diagnostics), and an aliquot was tested in duplicate each day for 12 days.
Statistical Analysis
EP Evaluator-CLIA software (David G. Rhoads Associates, Kennett Square, PA) was used for Deming regression analysis and supporting statistics.
Results
Variability in Manual Cell Counts
To determine imprecision in manual cell counts, 2 technologists loaded both sides of a Fuchs-Rosenthal counting chamber with glutaraldehyde-preserved human RBCs and counted the equivalent of 1 large square on each side of the chamber (0.4 µL total volume). The technologists then performed a cell count on the other person's chamber. This resulted in 2 counts for each of 2 counting chambers. This process was repeated a total of 5 times for each RBC concentration. Imprecision (expressed as CV %) was less than 5.9%, less than 8.2%, and less than 22.8% at mean cell counts of 983, 255, and 70 × 10 6 /L, respectively.
Variability in manual urine cell counts between technologists was examined by Deming regression analysis, and the statistics are shown in ❚Table 1❚. The slopes of the regression lines were not different from 1.0 for RBC and WBC counts. A slight bias in EC manual counts was observed based on a slope of 0.90. There was good correlation among counts for all 3 cell types based on r values of more than 0.97. RBC counts had the most dispersion around the regression line (S y/x , 40.1); this was most likely due to more samples containing higher numbers of RBCs compared with the other cell types.
Precision of the iQ200
Within-run imprecision of the iQ200 was evaluated by analyzing urine samples a total of 20 times during the same day for RBCs, WBCs, and ECs. As shown in ❚Table 2❚, imprecision for RBC counts was 5.6% (CV) or less at concentrations ranging from 786 to 1,029 × 10 6 /L and increased with decreasing cell numbers up to 29.6% for counts between 17 and 20 × 10 6 /L. Within-run CVs were slightly better for WBC counts with values of 3.4% or less and 22.3% or less at concentrations ranging from 794 to 1,006 × 10 6 /L and 16 to 30 × 10 6 /L, respectively. ECs had the highest CV of 31.3% in the concentration range of 13 to 22 × 10 6 /L. Between-run CVs for glutaraldehyde-preserved RBCs was lowest (3.3%) at a concentration of 1,017 × 10 6 /L and highest (19.2%) at the lowest cell concentration tested of 28 × 10 6 /L ❚Table 3❚.
Imprecision was examined further in urine samples at low cell concentrations. Overall, CVs increased with decreasing cell numbers and approached 45% for RBCs, 40% for WBCs, and 35% for ECs at the lowest cell concentrations ❚Figure 1❚. CVs of approximately 20% were found at RBC, WBC, and EC concentrations of 25, 18, and 21 × 10 6 /L, respectively (Figure 1 ).
Linearity and Carryover
To determine linearity, serial dilutions of urine samples with high concentrations of each cell type were made using a cell-free urine pool, and each dilution was tested in triplicate by the iQ200. RBC, WBC, and EC counts were linear up to 1,000, 900, and 100, respectively, based on slopes of 1.00 ± 0.01 and measured concentrations ± 10% of expected target values. Unfortunately, specimens with high numbers of ECs were not available during the study to validate linearity beyond 100 (× 10 6 /L) and confirm the manufacturer's linearity claim of 1,000. Carryover was determined by counting the negative control sample immediately after the positive control sample (fixed RBCs with a count of 1,000 × 10 6 /L) each day for 9 days and was found to be 0.2% or less. 
Correlation Studies
Correlation data for 166 urine samples with cell counts of 1 × 10 6 /L or more by both manual microscopy and the iQ200 are shown in ❚Figure 2❚. Overall, there was good agreement between the iQ200 and manual Fuchs-Rosenthal chamber counts for cellular elements based on r values of 0.940 to 0.959. The iQ200 exhibited a mean negative bias of 11.3% for RBCs, 24.7% for WBCs, and 4.3% for ECs compared with manual counts.
Of the 166 urine samples tested, only 20 (12%) had cell counts outside the 95% confidence interval of the regression lines (open circles, Figure 2 ). iQ200-stored images for these samples were reviewed manually to determine possible causes for the discrepancies. Seven samples had discrepant RBC counts, with 4 lower and 3 higher by the iQ200 ❚Table 4❚. Review of the images revealed that RBC discrepancies were due to abnormal RBC morphologic features (ghost and dysmorphic cells), trapping of RBCs in mucus strands, oval calcium oxalate crystals, and yeast. Ghost RBCs, mucus, and calcium oxalate crystals resulted in low or high iQ200 RBC counts, whereas dysmorphic RBCs and yeast produced low and high RBC counts, respectively. For WBCs, there were 8 discrepancies. Five were low and 3 were high by the iQ200. The low WBC counts were due to disintegrating and atypical WBCs that were classified as artifact by the iQ200. All high WBC counts were due to WBC clumps.
For ECs, there were 5 discrepant counts, with EC clumps accounting for 4. The remaining EC discrepancy was due to unusually wide hyaline casts being classified as ECs by the iQ200.
Clinical Performance of the iQ200
The ability of the iQ200 to correctly classify urine samples as having normal or abnormal RBC, WBC, and EC counts was examined using manual Fuchs-Rosenthal chamber counts as the comparison method. As shown in ❚Table 5❚, the agreement rate for the iQ200 ranged from 92.5% to 100% for samples classified as normal for each of the cell types. The agreement rate for abnormal samples was lower and ranged from 76.7% to 86.4%. Overall, the iQ200 had the highest agreement rate for ECs. Receiver operating characteristic area values for RBCs, WBCs, and ECs were 0.941, 0.931, and 0.970, respectively, indicating high diagnostic accuracy (data not shown). 
Cast Identification
In 24 samples, there were between 1 and 80 × 10 6 /L hyaline casts by both counting methods. The iQ200 detected more hyaline casts based on a Deming regression line slope of 1.74 (data not shown). The correlation coefficient was 0.91.
Manual editing of stored iQ200 images revealed that the APR overestimated hyaline cast counts in 2 samples with small numbers of hyaline casts (1-3 × 10 6 /L). Otherwise there was good agreement between counts generated by the APR software and after manual review of stored images.
Nine samples had nonhyaline casts that were placed in the unclassified pathologic cast category by the APR software. The APR software detected more pathologic casts than manual counting in 7 of 9 samples. There was good agreement between cast counts produced by the APR software and after manual review of images for all samples. In general, the quality of stored images was sufficient for subclassification of casts with the exception of cellular casts, in which the cellular detail was not always adequate for differentiation into cellspecific subcategories.
Discussion
The iQ200 is a new, automated, digital imaging-based system for routine identification of cells and particles in native urine. Features of individual images such as size, shape, contrast, and texture are used by the neural network pattern recognition software for classification into 1 of 12 particle categories. The results can be reported without operator review, or stored images in each category can be displayed on the screen for verification and/or manual editing. The iQ200 does not require continuous monitoring and can be connected to a reagent strip chemistry analyzer to provide a fully integrated chemical and microscopic urinalysis workstation. 14 Between-run imprecision of the iQ200 using fixed RBC counts was excellent at high cell counts based on CVs less than 7.5%. At lower cell counts, between-run imprecision was good, approaching 20% at counts below 30 × 10 6 /L. Withinrun precision for RBCs, WBCs, and ECs in urine samples was satisfactory at several cell concentrations, producing CVs of 25%, 15%, and 16% at the upper limits of normal for RBCs (17 × 10 6 /L), WBCs (28 × 10 6 /L), and ECs (28 × 10 6 /L), respectively. Overall, CVs for quantitation of cells by the iQ200 were smaller than those reported for manual cell counts. 5, 12, 15 Compared with other automated instruments, the iQ200 displayed similar 16, 17 or higher 2, 4, 18 CVs depending on the study design. The iQ200 was linear over a wide range of cell concentrations and had negligible carryover.
Although there was good correlation between methods for RBC, WBC, and EC counts (r values ranging from 0.940 to 0.959), the iQ200 identified fewer cells compared with manual cell counts using Fuchs-Rosenthal counting chambers. On average, cell counts by the iQ200 were 4.3% to 24.7% lower than manual counts depending on the cell type. The reasons for these differences in cell counting are unclear, but we considered that it could reflect inaccuracies associated with manual cell counting methods. 6, 7, 9 To address this, we minimized the imprecision of standardized manual chamber counts by averaging 4 separate counts (2 technologists' counts of 2 counting chambers). There was excellent correlation for urine cell counts between technologists (Table 1) . Thus, we do not believe that inaccuracies associated with the manual counting method can adequately explain the differences in cell counts between methods. It is interesting that the UF-100 automated instrument (TOA Medical Electronics, Kobe, Japan) also has been reported to produce lower cell counts than those obtained using Fuchs-Rosenthal counting chambers. 3 During this study, 20 urine samples were identified with cell counts falling outside the 95% confidence interval of the regression lines. Abnormal RBCs (some dysmorphic RBCs and ghost cells) and disintegrating WBCs accounted for many of these cases. The iQ200 counted distorted and disrupted cells as artifact, whereas this judgment would be highly subjective and would vary among technologists performing manual counts. Likewise, yeast and oval calcium oxalate crystals, which accounted for 2 of the discordant counts, could be confused with RBCs by automated and manual counting methods. It is interesting that one of the discrepancies due to calcium oxalate crystals resulted in a falsely high iQ200 count and the other a falsely high manual count.
Cell clumping also is problematic and can result in lack of agreement between methods depending on sample mixing before analysis. The iQ200 automatically resuspends particles in solution before testing by injecting a bolus of air into the sample. This might dissociate some of the cellular clumps, resulting in counts that are higher than those obtained by manual counting methods.
It is noteworthy that almost all of the discrepant results occurred at very high cell concentrations that would not have influenced clinical sensitivity. In fact, we found that the sensitivity of the iQ200 for detecting abnormal levels of RBCs, WBCs, and ECs was between 76% and 86%, whereas the specificity exceeded 92% for all 3 cell types.
Overall, the iQ200 detected more hyaline casts compared with manual cell counts. Although the reason for this is unclear, it might be related to the use of bright-field microscopy for manual cell counting. Hyaline casts are translucent, and some might have been missed by the reader, leading to falsely low cast counts. 11 Review of iQ200-stored images confirmed higher hyaline cell counts by the iQ200. In a handful of cases, the iQ200 overestimated the number of hyaline casts in samples with 1 to 3 casts (× 10 6 /L) by manual counts. In view of this, we agree with the manufacturer's recommendation that all casts should be verified for accuracy by manual review of stored images. Other types of casts also were identified, but owing to the small number of positive samples, additional studies are needed to evaluate the performance of the iQ200 in identifying pathologic casts. The iQ200 has satisfactory analytic performance for quantitation of RBCs, WBCs, and ECs and correlates well with Fuchs-Rosenthal manual chamber counts using uncentrifuged urine samples. Based on our findings, the majority of automated counts for RBCs, WBCs, and ECs can be reported without manual review of captured images. Exceptions include urine samples containing crystals and/or yeast that would require review of crystals and/or yeast images for confirmation, along with editing of the RBC, WBC, and EC images for accurate cell counts. This should require less than a minute per sample. In addition, WBC clumps will need to be verified by image review because several artifacts could be classified as cellular clumps. Last, based on limited data, we propose that the artifact category be reviewed for urine samples with 2+ protein or higher to detect small numbers of pathologic casts and should require no more than an additional 10 to 30 seconds. The iQ200 can be connected physically and electronically to a dry-reagent strip chemistry analyzer so that urine chemical analyses such as protein appear on the monitor next to the microscopic results.
